Ads
related to: ai therapy notes
Search results
North American Morning Briefing: Inflation Worries Overshadow AI Enthusiasm
Morningstar· 5 days agoOPENING CALL Stock futures inched higher on Friday, however, both the S&P 500 and the Dow industrials were on track to record their first weekly drops since mid-April, despite Nvidia surging to a record close. Concerns about price pressures were
Nurix Therapeutics enhances leadership team By Investing.com
Investing.com· 1 day agoNurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in cancer and...
Dow 2.8 million? It’s not even a stretch — for your grandchildren.
Market Watch· 6 days agoMorgan, whose wealth-management firm looks after $10 billion, shares a long-game lesson from his...
Your package wasn't delivered? Try living at one of L.A.'s '½' addresses
Los Angeles Times· 3 days agoCasey Hogan had no idea her new address would be so frustrating. Retail websites that are programmed...
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 18 hours agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
AP Business SummaryBrief at 12:25 a.m. EDT
The Valdosta Daily Times· 8 hours agoT-Mobile is buying U.S. Cellular’s wireless operations and certain spectrum assets in a deal valued at $4.4 billion, and further consolidating the industry. T-Mobile will get U.S. Cellular’s ...
After Pegasus Was Blacklisted, Its CEO Swore Off Spyware. Now He’s the King of Israeli AI.
The Intercept· 6 days agoShalev Hulio, once dubbed “Israel’s cyber bad boy,” has been working hard to remake himself. Things...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 6 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
Thermo Fisher sets quarterly dividend at $0.39 per share By Investing.com
Investing.com· 7 days agoThermo Fisher Scientific Inc. (NYSE: NYSE:TMO), a prominent player in serving the scientific...
Nyxoah sets price for U.S. public offering at $9.25 per share By Investing.com
Investing.com· 6 days agoMONT-SAINT-GUIBERT, Belgium - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology...
Ad
related to: ai therapy notes
